Industry News: Q-linea signs global partnership with Thermo Fisher Scientific for the commercialization of ASTar

New partnership provides Thermo Fisher Scientific the exclusive right to offer ASTar to the market in all geographies

13 Feb 2020

“We are very happy and proud to be able to present an important commercial milestone for both companies. The interest in commercializing ASTar has been very strong from a number of global companies. We are thrilled to be working with Thermo Fisher and especially appreciate their global reach. We share a common market view and agree on how infection diagnosis can be improved.” said Jonas Jarvius, CEO of Q-linea.

Thermo Fisher Scientificwill have the exclusive right to offer ASTar to the market in all geographies, with the exception that Q-linea can penetrate the Swedish market. The partnership is exclusive to both companies regarding fast AST testing. The two companies will work closely together to provide customers with a comprehensive AST portfolio.

Thermo Scientific Sensititre Complete Automated AST System is the industry standard for traditional MIC determination. Combining Thermo Fisher's long tradition, experience and strength in the field together with Q-linea's unique system for rapid and fully automatic AST analysis has the potential to greatly improve and speed up the diagnosis for patients with severe infectious diseases. 

“Thermo Fisher is a true market leader but is also a first in line in bringing new antibiotic preparations to the market for testing which is, of course, interesting for the future." said Jonas Jarvius, CEO of Q-linea.

“We are very excited by this partnership with Q-linea” said Christophe Fraudeau, President Microbiology, Thermo Fisher Scientific. “Our distribution agreement for the Q-linea ASTar technology will enable our customers to streamline their workflow.”

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>